Earnings Reported After The Bell Mar. 12

(RTTNews) - Here is a quick summary of the earnings reported after the bell Mar. 12.

1.Action sports retailer Zumiez Inc. (ZUMZ)

Net income for the fourth quarter was $17.5 million or $0.60 per share, compared to $26.9 million or $0.89 per share for the year-ago quarter.

Total net sales for the fourth quarter rose 14.0% to $258.6 million from $226.8 million a year earlier. Comparable sales for the 13-week period ended January 31, 2015 increased 8.3%.

Analysts polled by Thomson Reuters expected the company to earn $0.79 per share on revenue of $257.74 million for the fourth quarter. Analysts' estimates typically exclude special items.

Looking forward to the first quarter, the company forecasts net sales of $176 million to $178 million and earnings of $0.08 to $0.10 per share, which includes an estimated $1.1 million, or about $0.03 per share, for charges associated with the acquisition of Blue Tomato. Analysts currently expect the company to earn $0.14 per share on revenue of $181.29 million for the first quarter.

***

2. Dicerna Pharmaceuticals, Inc. (DRNA)

Net loss attributable to common shareholders for the fourth quarter was $14.6 million or $0.82 per share compared to a net loss of $6.7 million or $199.91 per share for the same period last year; Consensus $0.57 loss per share.

***

3. Charles & Colvard, Ltd. (CTHR)

Net loss for the fourth quarter was $2.8 million, or $0.14 per share, compared with a net income of $0.1 million, or $0.01 per share, in the year-ago fourth quarter.

Fourth quarter sales were $7.2 million compared with $8.6 million in the year-ago fourth quarter

Analysts expected the company to report net loss of $0.02 per share on revenues of $9.52 million for the period.

***

4.Aemetis, Inc. (AMTX)

The net loss was $3.7 million or $0.18 per share during the fourth quarter compared to $3.3 million or $0.16 per share for the fourth quarter last year.

Revenues were $41.5 million in the fourth quarter, declined 23% from $54.1 million last year.

***

5.ChipMOS Technologies Ltd. (IMOS)

Net income for the fourth quarter was US$18.7 million or US$0.63 per share, compared to US$5.4 million or US$0.18 per share for the year-ago quarter.

Net revenue for the fourth quarter rose 18.5% to US$183.4 million from US$154.7 million for the same quarter last year.

Analysts polled by Thomson Reuters expected the company to earn $0.41 per share on revenue of $188.35 million for the fourth quarter.

Looking forward, the company said it expects first quarter revenue to decrease about 8% to 12% sequentially.

***

6.Peregrine Pharmaceuticals, Inc. (PPHM)

Peregrine's consolidated net loss was $14.03 mln or $0.08 per share, for the third quarter compared to net loss of $9.72 mln or $0.06 per share, for the same quarter of the prior year.

Q3 revenue was $5.68 mln vs $3.89 mln a year ago.

Analysts expected the company to report net loss of $0.08 per share on revenues of $4.23 million for the period.

***

7.Towerstream Corporation (TWER)

Q4 net loss was $8.43 mln or $0.12 per share vs net loss of $6.77 mln or $0.10 per share a year ago.

Q4 revenue was $8.09 mln vs $8.52 mln a year ago.

Analysts expected the company to report net loss of $0.10 per share on revenues of $8.48 million for the period.

***

8.Kratos Defense & Security Solutions, Inc. (KTOS)

Net loss for the fourth quarter was $2.2 million or $0.04 per share, compared to a net loss of $7.4 million or $0.13 per share for the year-ago quarter.

Excluding items, adjusted earnings for the latest quarter were $6.1 million or $0.11 per share.

Total revenue for the fourth quarter fell to $221.5 million from $235.7 million a year earlier.

Analysts polled by Thomson Reuters expected the company to earn $0.07 per share on revenue of $231.68 million for the fourth quarter. Analysts' estimates typically exclude special items.

***

9.El Pollo Loco Holdings, Inc. (LOCO)

Q4 Net income was $4.6 million, or $0.12 per share, compared to a net loss of $18.1 million, or ($0.63) per share a year ago.

Q4 Proforma net income increased 60.6% to $5.5 million, or $0.14 per share, compared to $3.4 million, or $0.09 per share a year ago.

Q4 Total revenue was $90.0 million compared to $76.2 million a year ago.

Analysts expected the company to report net income of $0.12 per share on revenues of $87.48 million for the period.

FY Outlook

The company expects 2015 proforma net income per share ranging from $0.67 to $0.71; Consensus $0.68

***

10.KMG Chemicals, Inc. (KMG)

Q4 net income was $5.49 mln or $0.47 per share vs net loss of $2.74 mln or $0.24 per share a year ago.

Q4 non-GAAP net income was $3.53 mln or $0.30 per share vs $1.4 mln or $0.12 per share a year ago.

Q2 Consolidated net sales were $79.8 million vs $84.25 mln a year ago.

FY Outlook

Fiscal 2015 consolidated net sales to be in the range of $315 million -325 million

***

11.Ignite Restaurant Group (IRG)

Q4 Net loss was $48.5 million, or $1.89 per share, compared to a net loss of $4.4 million, or a loss of $0.17 per share in the fourth quarter last year.

Q4 Adjusted net loss was $6.4 million, or $0.25 per share, compared to an adjusted net loss of $4.1 million, or $0.16 per share in the fourth quarter last year.

Q4 Total revenues were $177.3 million, compared to $186.9 million in the fourth quarter a year ago.

Analysts expected the company to report net loss of $0.27 per share on revenues of $179.48 million for the period.

***

12.Gaiam, Inc. (GAIA)

Net income from continuing operations for the fourth quarter was $1.2 million or $0.03 per share,

Net loss for the fourth quarter was $2.4 million, or $0.10 per share, compared to a net loss of $30.4 million, or $1.29 per share, for the fourth quarter last year.

In the fourth quarter, net revenue was $55.4 million compared to net revenue of $50.8 million in the prior-year period.

Analysts expected the company to report net income of $0.12 per share on revenues of $54.25 million for the period.

***

13.Anacor Pharmaceuticals, Inc. (ANAC)

Q4 net loss was $10.12 mln or $0.24 per share vs net income of $130.75 mln or $3.01 per share a year ago.

Q4 revenue was $9.64 mln vs $8.49 mln a year ago.

***

14.RE/MAX Holdings, Inc. (RMAX)

Q4 net income was $2.38 mln or $0.20 per share vs $1.51 mln or $0.12 per share a year ago.

Q4 Revenue grew by 5.8% to $42.6 million from $40.23 mln a year ago.

Q1 Outlook

Revenue is estimated to increase in the range of 4% to 5% over first quarter a year ago.

FY Outlook

Revenue is estimated to increase in the range of 3% to 4% over last year.

***

15.Kindred Biosciences, Inc. (KIN)

For the fourth quarter, KindredBio reported a net loss of $6.8 million or $0.34 per share, as compared to a net loss of $2.4 million or $0.40 per share for the same period last year.

***

16. BioLife Solutions, Inc. (BLFS)

Q4 Net loss was $912,568 or $0.08 per share compared to a loss of $484,568 or $0.10 per share in the fourth quarter last year.

Q4 Total revenue was $1.7 million, down $0.6 million from $2.3 million in the fourth quarter last year.

***

17.Silvercrest Asset Management Group Inc. (SAMG)

Q4 net income was $1.22 mln or $0.15 per share vs $2.03 mln or $0.32 per share a year ago.

Q4 adjusted net income was $3.05 mln or $0.25 per share vs $1.87 mln or $0.15 per share a year ago.

Q4 revenue was $17.71 mln vs $17.16 mln a year ago.

Analysts expected the company to report net income of $0.23 per share on revenues of $18.23 million for the period.

***

18.Quantum Fuel Systems Technologies Worldwide, Inc. (QTWW)

The company reported Q4 net loss of $4.3 million or $0.18 per share vs net loss of $6.0 mln or $0.34 per share a year ago.

Total revenues amounted to $13.0 million for the fourth quarter vs $12.72 mln a year ago.

***

19.BioAmber Inc. (BIOA)

Q4 net loss was $4.36 mln or $0.20 per share vs net loss of $7.83 mln or $0.42 per share a year ago.

Q4 Product sales were $308000 vs $439000 a year ago.

***

20.Aéropostale Inc (ARO)

Fourth-quarter net loss was $13.5 million or $0.17 per share compared with a loss of $70.3 million or $0.90 per share last year.

Excluding items, adjusted earnings for the quarter were $0.01 per share compared with a loss of $0.35 per share a year ago.

Revenues for the quarter were down 11% at $593.8 million compared with $670 million in the prior year.

Analysts polled by Thomson Reuters estimated a loss of $0.03 per share on revenues of $576.8 million for the quarter. Analysts' estimates typically exclude special items.

Comparable sales for the quarter slid 9% compared with a drop of 15% in the prior year, the company said.

For the first quarter, the company expects a loss of $0.61 to $0.53 per share, and does not include the impact of any store impairments.

Analysts expect a loss of $0.36 per share for the quarter.

***

21.Hallmark Financial Services, Inc. (HALL)

Fourth quarter net income was $3.8 million, or $0.19 per share, compared to $3.4 million, or $0.18 per share a year ago; Consensus $0.15

Q4 net premiums earned were $83.45 mln vs $83.76 mln a year ago.

***

22.CTI BioPharma Corp. (CTIC)

Net loss for the fourth quarter was $44.2 million, or $0.27 per share, compared to a net income of $10.2 million, or $0.08 per share, for the same period last year.

Total revenues for the fourth quarter were $17.8 million compared to $32.9 million for the same period last year.

***

23.Fate Therapeutics, Inc. (FATE)

Q4 net loss was $6.23 mln or $0.30 per share vs net loss of $5.74 mln or $0.29 per share a year ago.

***

24.Diversified Restaurant Holdings, Inc. (BAGR)

Q4 net loss was $1.35 mln or $0.05 per share vs net loss of $177,539 or $0.01 per share a year ago.

Revenue for the fourth quarter increased 23.4% to $35.1 million compared to $28.5 million in the fourth quarter last year.

Consolidated comparable-store sales increased 5.8% in the fourth quarter compared to a 1.1% increase in the prior year period

FY Outlook

Revenue to be in the range of $148.0 million to $153.0 million

***

25.OncoMed Pharmaceuticals, Inc. (OMED)

Q4 net loss was $15.06 mln or $0.50 per share vs net loss of $4.34 mln or $0.15 per share a year ago.

Q4 revenue was $8.52 mln vs $18.98 mln a year ago.

***

26.TearLab Corporation (TEAR)

Q4 net loss was $6.9 million, or $0.21 per share vs net loss of $4.2 million, or $0.13 per share a year ago.

Q4 net revenues were $5.3 million, up 19% from $4.4 million for the same period last year.

***

27. QAD Inc. (QADA & QADB)

Q4 GAAP net income was $6.9 million, or $0.42 per Class A share and $0.36 per Class B share, compared with $4.3 million, or $0.27 per Class A share and $0.23 per Class B share a year ago.

Q4 Non-GAAP net income was $8.7 million, or $0.52 per Class A share and $0.46 per Class B share, compared with $5.5 million, or $0.35 per Class A share and $0.30 per Class B share a year ago.

Q4 revenue was $79.56 mln vs $73.53 mln a year ago.

Analysts expected the company to report net income of $0.27 per share on revenues of $79.56 million for the period.

Q1 Outlook

Total revenue of approximately $69 million

GAAP earnings per share of approximately breakeven.

Non-GAAP earnings per share of approximately $0.11 per Class A share and $0.09 per Class B share.

Analysts expect the company to report net income of $0.10 per share on revenues of $70.74 million for the period.

FY Outlook

Total revenue of approximately $302 million

GAAP earnings per share of approximately $0.49 per Class A share and $0.41 per Class B share.

Non-GAAP earnings per share of approximately $0.91 per Class A share and $0.76 per Class B share.

Analysts expect the company to report net income of $0.70 per share on revenues of $300.87 million for the period.

***

28.eMagin Corporation (EMAN)

Q4 Net loss was $1.6 million or $0.07 per share versus net loss of $8.7 million or $0.37 per share for the fourth quarter last year.

Revenues for the fourth quarter increased 10% to $6.7 million versus $6.1 million for the fourth quarter last year.

FY Outlook

eMagin expects revenues to be between $26 million and $29 million in 2015.

***

29.Beauty products retailer Ulta Beauty (ULTA)

Fourth-quarter net earnings were $87.3 million or $1.35 per share compared with $70.7 million or $1.09 per share last year.

Revenues for the quarter were up 20.7% at $1.05 billion compared with $868 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $1.27 per share on revenues of $1.02 billion for the quarter. Analysts' estimates typically exclude special items.

Comparable sales for the quarter were up 11.1%.

For the first quarter, Ultan Beauty expects earnings of $0.88 to $0.93 per share on revenues of $833 million to $847 million. Comparable sales are expected to increase 7% to 9%.

Analysts expect earnings of $0.91 per share on revenues of $832 million for the quarter.

For the full year 2015, the company expects earnings per share growth of 15% to 17%, excluding the $0.02 non-recurring tax benefit in the fourth quarter of 2014.

The company expects total sales growth in 2015 in the mid-teens percentage range and comparable sales growth of 6% to 8%.

Analysts expect earnings of $4.55 per share on revenue growth of 15.7% in 2015.

***

30.Gastar Exploration Inc. (GST)

Net income for the fourth quarter was $26.7 million, or $0.34 per share vs net loss of $3.3 million, or $0.06 per share a year ago.

Q4 adjusted net income was $1.8 million, or $0.02 per share vs $698,000, or $0.01 per share a year ago; Consensus $0.05

Q4 revenue was $61.45 mln vs $26.73 mln a year ago.

***

31. InspireMD, Inc. (NSPR)

Net loss for the fourth quarter was $4.8 million, or $0.12 per share, compared to a net loss of $5.4 million, or $0.16 per share, in the same period last year.

Non-GAAP net loss for the quarter was $3.8 million, or $0.09 per share compared to non-GAAP net loss of $4.5 million, or $0.13 per share, for the same period last year.

Q4 Revenue decreased $0.7 million to $0.9 million from $1.6 million during the same period a year ago.

***

32.Imprimis Pharmaceuticals, Inc. (IMMY)

Q4 net loss was $2.75 mln or $0.30 per share vs net loss of $1.88 mln or $0.21 per share a year ago.

Q4 revenue was $550.105 vs $2,500 a year ago.

***

33.Trovagene, Inc. (TROV)

For the fourth quarter, Trovagene reported net loss of $4.7 million, or $0.25 per share, as compared to net loss of $1.0 million, or $0.05 per share, for the quarter ended a year ago.

Q4 revenue was $56000 vs $47000 a year ago.

***

34.Medifast, Inc. (MED)

Q4 Income from continuing operations was $2.6 million, or $0.21 per share, compared to $7.2 million, or $0.53 per share, for the fourth quarter last year.

Q4 Adjusted income from continuing operations for the fourth quarter was $4.6 million, or $0.38 per share as compared to $7.2 million, or $0.53 per share, for the fourth quarter a year ago; Consensus $0.46

For the fourth quarter, Medifast net revenue decreased 11% to $62.3 million from $70.3 million in the fourth quarter last year.

Q1 Outlook

The company expects first quarter 2015 net revenue from continuing operations to be in the range of $70.0 million to $73.0 million and earnings per share from continuing operations in the range of $0.33 to $0.35.

Analysts expect the company to report net income of $0.43 per share on revenues of $83.70 million for the period.

FY Outlook

For fiscal year 2015, the company expects revenue from continuing operations to be in the range of $285 million to $300 million and earnings per share from continuing operations in the range of $1.85 to $1.95.

Analysts expect the company to report net income of $1.83 per share on revenues of $307.77 million for the period.

***

35.FXCM Inc. (FXCM)

Net income attributable to the company for the fourth-quarter rose to $15.8 million or $0.35 per share, from $3.0 million or $0.08 per share for the fourth quarter last year.

Net income on an adjusted basis was $16.1 million or $0.20 per fully diluted, fully exchanged share for the fourth quarter 2014, compared to Net income on an adjusted basis of $7.3 million or $0.10 per fully diluted, fully exchanged share for the fourth quarter 2013.

Revenues of $134.7 million, compared to $113.3 million for the quarter ended December 31, 2013, an increase of 19%.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.17 per share and revenues of $129.92 million for the quarter. Analysts' estimates typically exclude special items.

***

36.Athersys, Inc. (ATHX)

Q4 Net loss was $6.6 million or $0.08 per share compared to $9.8 million or $0.15 per share for the same period last year.

Q4 evenues were $0.2 million compared to $0.9 million in the same period last year.

***

37.Gas Natural Inc. (EGAS)

Income from continuing operations was $1.2 million, or $0.11 per share, for the fourth quarter, compared with $2.8 million, or $0.27 per share, for the fourth quarter last year.

Adjusted income from continuing operations was $3.0 million, or $0.28 per share, for the fourth quarter compared with $2.5 million, or $0.24 per share, for the fourth quarter last year.

Q4 revenue was $36.96 mln vs $36.29 mln a year ago.

***

38.FTD Companies, Inc. (FTD)

Net income increased $6.3 million to $3.9 million or $0.19 per share for the fourth quarter compared to net loss of $2.5 million or $0.13 per share in the same period of the prior year.

Adjusted Net Income decreased slightly to $10.4 million compared to $10.6 million in the same period of the prior year.

Consolidated revenues increased 2.1% to $157.5 million for the fourth quarter compared to $154.3 million in the same period of the prior year.

FY Outlook

For the full year 2015, the company expects consolidated revenues to be flat to down modestly compared with last year

***

39.Avinger, Inc., (AVGR)

Q4 net loss was $8.14 mln or $33.62 per share vs net loss of $8.6 mln or $36.14 per share a year ago.

Total revenue was $3.1 million for the fourth quarter, a decrease of 9% from $3.4 million in the comparable period a year ago.

FY Outlook

The company expects 2015 revenue to be in the range of $12 million to $14 million

***

40.ChemoCentryx, Inc., (CCXI)

Net loss was $12.2 million or $0.28 per share for the fourth quarter compared to $9.5 million or $0.22 per share in the same period last year.

There was no revenue recognized for the fourth quarter compared to $0.7 million in the same period last year.

***

41. Identiv, Inc. (INVE)

Net loss from continuing operations was $(6.2) million in the fourth quarter, or $(0.58) per share, compared with net loss of $(3.0) million, or $(0.88) per share a year ago.

For the fourth quarter, total revenues for continuing operations were $19.4 million vs $19.5 million a year ago.

FY Outlook

Fiscal year 2015 revenue to be between $95 million and $105 million

*** 42.Jamba Inc (JMBA)

Fourth-quarter net loss was $8 million or $0.47 per share compared with a loss of $5.7 million or $0.33 per share last year.

Excluding transitional costs, adjusted loss for the quarter was $0.27 per share. Analysts polled by Thomson Reuters estimated a loss of $0.34 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues for the quarter were lower at $43.9 million compared with $44.1 million in the prior year. Analysts estimated revenues of $44.9 million for the quarter.

Jamba said system-wide comparable store sales increased 4.9% in the quarter, and sales on this basis at company-owned stores were up 4.2%, and franchise-operated stores rose 5.4%.

For the full year 2015, Jamba expects company-owned comparable store sales growth of 3% to 5%.

***

43.Information Services Group, Inc. (III)

Net income for the fourth quarter was $0.7 million or $0.02 per share down from $1.0 million or $0.03 per share last year.

Adjusted net income for the fourth quarter was $2.2 million or $0.06 per share compared with $2.1 million or $0.05 per share in the prior year; Consensus $0.04

ISG reported fourth-quarter revenues of $53.2 million vs $53.4 million in the fourth quarter last year.

FY Outlook

For 2015, ISG is targeting growth in revenues in the range between 6% and 8% ; Consensus 6.1%.

***

44.Luna Innovations Incorporated (LUNA)

Net loss attributable to common stockholders for the fourth quarter improved $1.1 million to $0.9 million or $0.06 per share compared to a net loss attributable to common stockholders of $2.0 million or $0.15 per share for the fourth quarter last year.

Total revenue for the fourth quarter increased 32%, to $6.2 million, compared to $4.7 million in the fourth quarter last year.

***

45.Cytori Therapeutics (CYTX)

Q4 net loss was $6.9 million or $0.08 per share vs net loss of $10 million or $0.14 per share a year ago.

Q4 revenue was $3.8 million vs $3.5 million a year ago.

***

46.Hill International (HIL)

Net loss for the fourth quarter was ($3.5 million), or ($0.07) per share, compared to a net loss of ($1.3 million), or ($0.03) per share, in the fourth quarter last year.

Total revenue for the fourth quarter was $169.1 million, an increase of 16.7% from $144.95 mln in the fourth quarter last year.

***

47.Rare Element Resources Ltd. (REE)

Net loss for the fourth quarter was $2.9 million, or $0.06 per share, compared with $5.7 million, or $0.12 per share, for the same period last year.

***

48.Avalon Holdings Corporation (AWX)

Q4 net loss was $0.4 million, or $.10 per share compared to a net loss of $0.3 million, or $.08 per share in the fourth quarter last year.

Net operating revenues in the fourth quarter were $14.0 million compared with $12.7 million in the fourth quarter last year.

***

49.Adams Resources & Energy, Inc., (AE)

Fourth quarter net loss was $6.67 mln or $1.58 per common share vs net earnings of $109,000 or $.02 per share for the fourth quarter last year.

Q4 revenues were $849.74 mln vs $968.1 mln a year ago.

***

50. Aratana Therapeutics, Inc. (PETX)

Q4 net loss was $10.26 mln or $0.30 per share vs net income of $4.47 mln or $0.20 per share a year ago.

Q4 revenue was $248000 vs $123000 a year ago.

***

51.FutureFuel Corp (FF)

Fourth-quarter net earnings were $30.1 million or $0.69 per share compared with $26.5 million or $0.61 per share last year.

The company's revenues for the quarter dropped 30% to $88.5 million from $125.6 million in the prior year. Analysts polled by Thomson Reuters estimated revenues of $88.4 million for the quarter.

***

52.Fortuna Silver Mines Inc. (FSM)

Fourth quarter net income was to $0.1 million or $0.00 per share vs net loss of $14.9 million or $0.12 per share a year ago.

Q4 Adjusted net income was $0.2 million, compared to $3.0 million in the fourth quarter last year.

Q4 Sales were $37.8 million, 4% increase over the fourth quarter a year ago.

Analysts expected the company to report net income of $0.03 per share on revenues of $44.6 million for the period.

***

53.Civeo Corporation (CVEO)

Net loss for the fourth quarter was $271.6 million, or $2.54 per share vs net income of $45.5 million, or $0.43 per share a year ago.

Q4 adjusted net income was $18.0 million or $0.19 per share.

In the fourth quarter, the company generated revenues of $219.7 million vs $258.5 million a year ago,

Analysts expected the company to report net income of $0.13 per share on revenues of $205.07 million for the period.

***